Академический Документы
Профессиональный Документы
Культура Документы
A. Induced emesis
B.Gastric emptying or Gastric lavage (GL)
C. Activated charcoal combined with a cathartic
D.Whole-bowel irrigation(WBI)
Emesis
• Considered only in fully alert patients, and is
virtually never indicated after hospital
admission
• Contraindications to its use include poisoning
with corrosives, petroleum products, or
antiemetics.
A. Induced Emesis
• Induced emesis utilizes syrup of ipecac to induce
vomiting, theoretically emptying the stomach
and reducing absorption of an ingested agent.
• Syrup of ipecac induces vomiting by activation of
both local and central emetic sensory receptors.
• Induced emesis has largely been abandoned in
clinical practice.
• The most recent policy statements released by
both the American Academy of Pediatrics(2003)
and the American Association of Poison Control
Centers (2005) discourage the use of syrup of
ipecac in the out-of-hospital setting.
Gastric Emptying
• GL through a 28F to 40F Ewald tube is similarly
aimed at physically removing a toxin
• Prior to inserting the Ewald tube, the mouth should
be inspected for foreign material and equipment
should be ready for suctioning
• Large gastric tubes (37F to 40F) are less likely to
enter the trachea than smaller nasogastric tubes, and
are necessary to facilitate removal of gastric debris
• Nonintubated patients must be alert (and be
expected to remain alert) and have adequate
pharyngeal and laryngeal protective reflexes
• In semicomatose patients, GL should be
performed only after a cuffed endotracheal
tube has been inserted.
• GL is performed by instilling 200-mL aliquots of warmed tap
water until there is clearing of aspirated fluid
• Stomach contents should be retained for analysis
• Tap water may avoid unnecessary salt loading compared to
normal saline solution
• Neither irrigant has been shown to significantly alter blood
cell or electrolyte concentrations
• After clearing, the Ewald tube may be replaced by a
nasogastric tube for subsequent intermittent suctioning
and/or administration of activated charcoal.
does not recommend routine use of GL in the
management of poisoning unless a patient has
AMERICAN
ingested ACADEMY
a potentially OF CLINICAL
life-threatening amount of a
poison and the procedure can be undertaken
TOXICOLOGY
within 60 min of ingestion
B. Gastric Lavage
INDICATIONS CONTRAINDICATIONS
• Ingestion of a substance ■ Substance not meeting above
with high toxic potential indications
and: ■ Spontaneous emesis
■ Within 1 hour of ingestion ■ Diminished level of
consciousness/unprotected
■ Ingested substance is not
airway reflexes (intubate first)
bound by activated
charcoal or has no effective ■ Ingestion of hydrocarbons or
caustic agents
antidote.
■ Foreign body ingestion
■ Potential benefits outweigh
■ Patient is at high risk for
risks. esophageal or gastric injury (GI
hemorrhage, recent surgery,
etc.).
TECHNIQUE
■ Recommended tube size is 36–40 French for adults,
22–28 French for children.
■ Secure airway via intubation, if necessary.
■ Position patient in left-lateral decubitus position, with head
lowered below level of feet.
■ Confirm tube placement following insertion.
■ Aspirate any available stomach contents.
■ Lavage with 250 mL (10–15 mL/kg in children) aliquots of
warm water or saline.
■ Continue until fluid is clear and a minimum of 2L has been
used.
■ Instill activated charcoal through same tube, if indicated.
COMPLICATIONS
■ The primary risks are vomiting, aspiration, and esophageal
injury or perforation.
C. Activated Charcoal
INDICATIONS CONTRAINDICATIONS
RISKS
The risks associated with MDAC are similar
to those with AC; however,there is a greater risk
of bowel obstruction with MDAC.
INDICATIONS CONTRAINDICATIONS
■ Phenobarbital
■ Carbamazepine (Tegretol)
■ Theophylline
■ Aspirin
■ Dapsone
B. Urinary Alkalinization
Urinary alkalinization attempts to increase renal
elimination of a drug by increasing urine pH.
RISKS
Can precipitate hypokalemia and decrease ionized
calcium levels
INDICATIONS CONTRAINDICATIONS
RISKS
■ HD requires central venous access, with all the usual
accompanying risks
(bleeding, pneumothorax, etc.).
■ HD must be used cautiously in patients that are
hemodynamically unstable.
INDICATIONS CONTRAINDICATIONS